Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment
Top Cited Papers
- 28 February 2009
- journal article
- Published by Elsevier BV in Water Research
- Vol. 43 (3), 831-841
- https://doi.org/10.1016/j.watres.2008.11.043
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- First Evidence for Occurrence of Hydroxylated Human Metabolites of Diclofenac and Aceclofenac in Wastewater Using QqLIT-MS and QqTOF-MSAnalytical Chemistry, 2008
- Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologiesScience of The Total Environment, 2007
- Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactorAnalytical and Bioanalytical Chemistry, 2006
- Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification schemeWater Research, 2006
- Removal of pharmaceuticals and fragrances in biological wastewater treatmentWater Research, 2005
- Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving watersWater Research, 2005
- Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge processWater Research, 2005
- A rapid method to measure the solid–water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludgeWater Research, 2004
- Aquatic environmental assessment of the top 25 English prescription pharmaceuticalsWater Research, 2002
- Occurrence of drugs in German sewage treatment plants and riversWater Research, 1998